STOCK TITAN
  1. Home
  2. Sec-filings
  3. AMGN
  4. [ARS] AMGEN INC SEC Filing

[ARS] AMGEN INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - AMGEN INC

ARS Filing - AMGEN INC

This filing is available as a PDF document.

Filing Type: ARS

Company: AMGEN INC (AMGN)

Acceptance Date: 2026-03-31T09:00:13.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Amgen Inc

NASDAQ:AMGN

View AMGN Stock Overview →

AMGN Rankings

#69 Ranked by Market Cap
N/A Ranked by Dividends
#1630 YTD Gainer
#4027 Monthly Gainer

AMGN Latest News

Apr 6, 2026
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Apr 1, 2026
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
Mar 28, 2026
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
Mar 5, 2026
AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE
Mar 4, 2026
AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND

AMGN Latest SEC Filings

Apr 7, 2026
[DEF 14A] AMGEN INC Definitive Proxy Statement
Mar 26, 2026
[SCHEDULE 13G/A] AMGEN INC Amended Passive Investment Disclosure
Mar 18, 2026
[Form 4] AMGEN INC Insider Trading Activity
Mar 18, 2026
[Form 4] AMGEN INC Insider Trading Activity
Mar 18, 2026
[Form 4] AMGEN INC Insider Trading Activity

AMGN Stock Data

184.67B
537.76M
Drug Manufacturers - General
Biological Products, (no Diagnostic Substances)
Link
United States
THOUSAND OAKS